ATE498679T1 - Neuer, dem wirt gegen krankheiten gerichtete eigenschaften verleihender stamm und bakterienzellzusammensetzung - Google Patents

Neuer, dem wirt gegen krankheiten gerichtete eigenschaften verleihender stamm und bakterienzellzusammensetzung

Info

Publication number
ATE498679T1
ATE498679T1 AT05851002T AT05851002T ATE498679T1 AT E498679 T1 ATE498679 T1 AT E498679T1 AT 05851002 T AT05851002 T AT 05851002T AT 05851002 T AT05851002 T AT 05851002T AT E498679 T1 ATE498679 T1 AT E498679T1
Authority
AT
Austria
Prior art keywords
bacterial cell
cell composition
new host
treating
disease strain
Prior art date
Application number
AT05851002T
Other languages
English (en)
Inventor
Takehiro Miwa
Hiroshi Watanabe
Mamoru Ishihara
Tsuneo Hino
Narito Asanuma
Original Assignee
Meiji Seika Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha filed Critical Meiji Seika Kaisha
Application granted granted Critical
Publication of ATE498679T1 publication Critical patent/ATE498679T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Physiology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
AT05851002T 2004-12-28 2005-12-28 Neuer, dem wirt gegen krankheiten gerichtete eigenschaften verleihender stamm und bakterienzellzusammensetzung ATE498679T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004379693 2004-12-28
PCT/JP2005/024144 WO2006070891A1 (ja) 2004-12-28 2005-12-28 宿主に対して抗病性を付与する新規な菌株および菌体組成物

Publications (1)

Publication Number Publication Date
ATE498679T1 true ATE498679T1 (de) 2011-03-15

Family

ID=36615002

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05851002T ATE498679T1 (de) 2004-12-28 2005-12-28 Neuer, dem wirt gegen krankheiten gerichtete eigenschaften verleihender stamm und bakterienzellzusammensetzung

Country Status (12)

Country Link
US (1) US8728794B2 (de)
EP (1) EP1835021B1 (de)
JP (1) JP4953824B2 (de)
KR (1) KR101102914B1 (de)
CN (1) CN101124318B (de)
AT (1) ATE498679T1 (de)
BR (1) BRPI0519426A2 (de)
DE (1) DE602005026452D1 (de)
DK (1) DK1835021T3 (de)
ES (1) ES2358746T3 (de)
PT (1) PT1835021E (de)
WO (1) WO2006070891A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110059168A1 (en) * 2009-09-09 2011-03-10 Ang Sam Method for correcting intestinal glutamine synthetase deficiency
KR101371554B1 (ko) 2011-12-21 2014-03-10 한국해양과학기술원 항균 활성을 포함한 다양한 생리 활성을 가지는 신규의 지방산, 이 지방산을 생성하는 해양 미생물 및 이 지방산의 제조방법
WO2013130773A2 (en) 2012-02-29 2013-09-06 Ethicon Endo-Surgery, Inc. Compositions of microbiota and methods related thereto
KR101364747B1 (ko) * 2013-12-03 2014-02-27 한국해양과학기술원 항균 활성을 포함한 다양한 생리 활성을 가지는 신규의 지방산, 이 지방산을 생성하는 해양 미생물 및 이 지방산의 제조방법
KR101364748B1 (ko) 2013-12-03 2014-02-27 한국해양과학기술원 항균 활성을 포함한 다양한 생리 활성을 가지는 신규의 지방산, 이 지방산을 생성하는 해양 미생물 및 이 지방산의 제조방법
KR101364749B1 (ko) 2013-12-03 2014-02-27 한국해양과학기술원 항균 활성을 포함한 다양한 생리 활성을 가지는 신규의 지방산, 이 지방산을 생성하는 해양 미생물 및 이 지방산의 제조방법
EP4529950A3 (de) 2014-10-31 2025-08-20 Pendulum Therapeutics, Inc. Verfahren und zusammensetzungen im zusammenhang mit mikrobieller behandlung von störungen
KR20170103920A (ko) * 2015-01-09 2017-09-13 바게닝겐 유니버시테이트 위장관, 대사성 및/또는 기타 질환의 치료 및/또는 예방을 위한 박테리아-함유 조성물 및 이의 사용 방법
WO2019046646A1 (en) 2017-08-30 2019-03-07 Whole Biome Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
CA3106315A1 (en) 2018-07-19 2020-01-23 Pendulum Therapeutics, Inc. Methods and compositions for microbial engraftment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5104198A (en) 1996-11-05 1998-05-29 Wisconsin Alumni Research Foundation Use of conjugated linoleic acid to enhance natural killer lymphocyte function
JP2003073269A (ja) 1998-03-17 2003-03-12 Conlinco Inc 共役リノール酸組成物
US6696584B2 (en) 1998-05-04 2004-02-24 Natural Asa Isomer enriched conjugated linoleic acid compositions
WO2002080947A1 (fr) 2001-04-06 2002-10-17 Kyodoken Institute For Animal Science Research & Development Compositions contenant une bacterie pouvant convertir de l'acide lactique en acide butyrique, et methode utilisant ces compositions pour prevenir ou traiter l'hyperlactacidemie dans le systeme digestif ou le cancer du colon
US6677470B2 (en) 2001-11-20 2004-01-13 Natural Asa Functional acylglycerides
KR100516377B1 (ko) * 2002-04-12 2005-09-26 (주)케비젠 공역화 리놀렌산을 생산하는 신규한 균주, 이를 함유하는 캡슐제 및 이를 이용한 기능성 식품
ES2204328B1 (es) 2002-10-04 2005-09-01 Consejo Sup. De Invest. Cientificas Procedimiento de produccion de acidos grasos polinsaturados con levaduras por incorporacion de sustratos olefinicos o acetilenicos.
CN1248697C (zh) * 2003-11-13 2006-04-05 荀涣仁 一种治疗慢性肠炎的药物组合物及其制备方法

Also Published As

Publication number Publication date
EP1835021A4 (de) 2008-11-05
WO2006070891A1 (ja) 2006-07-06
BRPI0519426A2 (pt) 2009-01-20
PT1835021E (pt) 2011-04-29
US8728794B2 (en) 2014-05-20
CN101124318A (zh) 2008-02-13
ES2358746T3 (es) 2011-05-13
EP1835021B1 (de) 2011-02-16
DK1835021T3 (da) 2011-04-18
CN101124318B (zh) 2013-01-09
JPWO2006070891A1 (ja) 2008-06-12
JP4953824B2 (ja) 2012-06-13
KR101102914B1 (ko) 2012-01-10
US20080095745A1 (en) 2008-04-24
EP1835021A1 (de) 2007-09-19
KR20070091212A (ko) 2007-09-07
DE602005026452D1 (de) 2011-03-31

Similar Documents

Publication Publication Date Title
BRPI0506713A (pt) composições de ácido peroxicarboxìlico de cadeia média
ATE530669T1 (de) Markierte mikroorganismen und entsprechende markierungsverfahren
BRPI0715243A2 (pt) "método de aumento da produção de etanol e linhagem de z. mobilis"
EP1971366A4 (de) Menschliche anti-il-23-antikörper, zusammensetzungen, verfahren und verwendungen
EP1943348A4 (de) Zusammensetzungen, verfahren und kits zur amplifikation von nukleinsäuren
NO20074179L (no) Prodrugs av 2,4-pyrimidindiaminforbindelser og deres anvendelse
NO20076059L (no) 2,4-Diamino-pyrimidiner anvendt som aurorainhibitorer
DE602006015665D1 (de) Probiotische enterokokken für eine verbesserte immunität
NO20082240L (no) GLP-2 imitatorstoff, polypeptider, sammensetninger, fremgangsmater og anvendelser
EP1863507A4 (de) Zusammensetzungen und verfahren zur behandlung von akne
EP2089510A4 (de) Aus dem amnion gewonnene stammzellen und verwendungen davon
WO2005003320A3 (en) Neuronal differentiation of stem cells
BRPI0513897A (pt) diferenciação de células-tronco
EA200802054A1 (ru) Ингибиторы фермента
ATE498679T1 (de) Neuer, dem wirt gegen krankheiten gerichtete eigenschaften verleihender stamm und bakterienzellzusammensetzung
NO20075368L (no) Antiinflammatoriske modaliteter
DK1748068T3 (da) Fremgangsmåde til dyrkning af en lipidproducerende stamme og udnyttelse deraf
TW200942549A (en) Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of TRPV1
EP2215250A4 (de) Enzyme zur amplifikation und zum kopieren bisulphit-modifizierter nukleinsäuren
EP1771558A4 (de) Hemmung von biofilmbildung
DE602005003507D1 (de) Mikroorganismus isoliert vom Kefir, die Mikroorganismuskultur und die Produkte die diesen Mikroorganismus oder die Mikroorganismuskultur enthalten
FR2881751B1 (fr) Compositions comprenant des micro-organismes deshydrates, leurs procedes de preparation, et leurs utilisations
NO20073276L (no) Metode for fremstilling av aminoetoksybenzylalkoholer
EP1928490A4 (de) Zusammensetzungen und verfahren zur verwendung von chondroitinase-abci-mutanten
DE602005024194D1 (de) Peroxidase-Herstellung aus Pflanzenzellen und Callus-Kulturen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties